Financial Enhancement Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-810
| Closed | -$40K | – | 247 |
|
|
2022
Q3 | $40K | Hold |
810
| – | – | 0.01% | 148 |
|
|
2022
Q2 | $45K | Hold |
810
| – | – | 0.01% | 140 |
|
|
2022
Q1 | $45K | Buy |
810
+50
| +7% | +$2.78K | 0.01% | 141 |
|
|
2021
Q4 | $43K | Sell |
760
-40
| -5% | -$2.26K | 0.01% | 144 |
|
|
2021
Q3 | $38K | Hold |
800
| – | – | 0.01% | 146 |
|
|
2021
Q2 | $34K | Hold |
800
| – | – | 0.01% | 140 |
|
|
2021
Q1 | $27K | Hold |
800
| – | – | 0.01% | 141 |
|
|
2020
Q4 | $28K | Hold |
800
| – | – | 0.01% | 161 |
|
|
2020
Q3 | $28K | Hold |
800
| – | – | 0.01% | 143 |
|
|
2020
Q2 | $26K | Hold |
800
| – | – | 0.01% | 149 |
|
|
2020
Q1 | $24K | Hold |
800
| – | – | 0.01% | 156 |
|
|
2019
Q4 | $23K | Hold |
800
| – | – | 0.01% | 160 |
|
|
2019
Q3 | $21K | Hold |
800
| – | – | 0.01% | 163 |
|
|
2019
Q2 | $20K | Hold |
800
| – | – | 0.01% | 163 |
|
|
2019
Q1 | $21K | Buy |
+800
| New | +$21K | 0.01% | 177 |
|